Kolexia
Hentic-Dhome Olivia Gastro-entérologie
Hentic-Dhome Olivia
Gastro-entérologie
Hôpital Beaujon
Clichy, France
178 Activités
3 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs neuroendocrines Tumeurs du pancréas Métastase tumorale Tumeurs du foie Carcinomes Pancréatite Adénocarcinome Carcinome neuroendocrine Tumeurs gastro-intestinales

Collaborateurs

Voir plus
Ruszniewski Philippe
Ruszniewski Philippe
Hôpital Beaujon, Clichy, France
Hammel Pascal
Hammel Pascal
Hôpital Paul Brousse, Villejuif, France
Rebours Vinciane
Rebours Vinciane
Hôpital Beaujon, Clichy, France
Couvelard Anne
Couvelard Anne
Hôpital Bichat-Claude-Bernard, Paris, France

Industries

Voir plus
Ipsen
11 collaboration(s)
Dernière en 2023
Advanced Accelerator Applications
7 collaboration(s)
Dernière en 2023
ADVANCED ACCELERATOR APPLICATIONS
3 collaboration(s)
Dernière en 2023
ESTEVE PHARMACEUTICALS S.A.S
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
BETTER2: Randomized Phase 2 Trial Of Two Chemotherapy Regimens Plus Or Minus Bevacizumab In Patients With Well Differentiated Pancreatic Neuroendocrine Tumors
Essai Clinique (Gustave-Roussy)   07 février 2024
ASPEN: A Prospective Evaluation of the Management of Sporadic Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Neoplasms ≤ 2 cm
Essai Clinique (IRCCS San Raffaele)   17 janvier 2024
Appropriate use of morphological imaging for assessing treatment response and disease progression of neuroendocrine tumors.
Best practice & research. Clinical endocrinology & metabolism   13 octobre 2023
LBA54 Alkylating agent-based vs oxaliplatin-based chemotherapy in neuroendocrine tumours according to the O6-methylguanine-DNA methyltransferase (MGMT) status: A randomized phase II study (MGMT-NET) on behalf of the French Group of Endocrine Tumors (GTE) and ENDOCAN-RENATEN network
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
High Tumor Uptake on F-FDOPA PET/CT Indicates Poor Prognosis in Patients with Metastatic Midgut Neuroendocrine Tumors: A Study from the Groupe d'étude des Tumeurs Endocrines and ENDOCAN-RENATEN Network.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   31 août 2023
Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours.
Heart (British Cardiac Society)   18 juillet 2023
NEONEC: Phase II Study to Evaluate the Efficacy of 12-month Neoadjuvant Chemotherapy in Terms of Disease-free Survival in Patients With Localized Digestive Neuroendocrine Carcinomas
Essai Clinique (GERCOR (Multidisciplinary Group in Oncology))   28 juin 2023
Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms.
Therapeutic advances in medical oncology   09 juin 2023
Classification of PRSS1 variants responsible for chronic pancreatitis: An expert perspective from the Franco-Chinese GREPAN study group.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   20 avril 2023
BEVANEC: Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment After the Failure of the Cisplatin (or Carboplatin)-Etoposide Combination in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer. A Phase 2 Non-comparative Randomized Study
Essai Clinique (Hospices Civils de Lyon)   18 avril 2023